We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
+5.95%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$333M
AUM Growth
+$80.2M
Cap. Flow
+$69.2M
Cap. Flow %
20.77%
Top 10 Hldgs %
65.42%
Holding
54
New
15
Increased
11
Reduced
11
Closed
11

Top Buys

Rank Stock Value
1
HUMA icon
Humacyte
HUMA
+$7.25M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$6.51M
3
XAIR icon
Beyond Air
XAIR
+$6.38M
4
IPWR icon
Ideal Power
IPWR
+$6.06M
5
IMMX icon
Immix Biopharma
IMMX
+$6.02M

Top Sells

Rank Stock Value
1
ASPN icon
Aspen Aerogels
ASPN
+$28.5M
2
INDI icon
indie Semiconductor
INDI
+$18.3M
3
TGAN
Transphorm, Inc. Common Stock
TGAN
+$16.9M
4
SPRB
Spruce Biosciences
SPRB
+$6.22M
5
LPSN icon
LivePerson
LPSN
+$6.1M

Sector Composition

Rank Sector Weight
1 Healthcare 42.11%
2 Technology 14.5%
3 Industrials 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCAT icon
26
Red Cat Holdings
RCAT
$1.41B
$3.8M 1.14%
4,964,873
-61,231
-1% -$45.3K
APRE icon
27
Aprea Therapeutics
APRE
$8.19M
$3.5M 1.05%
539,300
+190,000
+54% +$1.18M
CGTX icon
28
Cognition Therapeutics
CGTX
$95.8M
$3.45M 1.04%
1,897,273
-141,580
-7% -$292K
INAB icon
29
IN8bio
INAB
$9.64M
$3.39M 1.02%
95,832
-40,780
-30% -$1.54M
ADVM
30
DELISTED
Adverum Biotechnologies
ADVM
$2.3M 0.69%
162,547
-154,735
-49% -$2.35M
PYPD icon
31
PolyPid
PYPD
$92M
$2.27M 0.68%
+479,246
New +$2.9M
HELP
32
Cybin Inc
HELP
$714M
$1.85M 0.56%
+122,399
New +$1.77M
GRCE
33
Grace Therapeutics
GRCE
$34.7M
$1.71M 0.51%
+497,359
New +$1.47M
KPRX icon
34
Kiora Pharmaceuticals
KPRX
$11.7M
$1.62M 0.49%
+255,556
New +$1.43M
ELUT icon
35
Elutia
ELUT
$37.6M
$1.38M 0.41%
436,566
-1,263,434
-74% -$4.38M
BWAY
36
Brainsway
BWAY
$622M
$1.29M 0.39%
485,872
-1,591,184
-77% -$4.96M
FKWL icon
37
Franklin Wireless
FKWL
$27.2M
$1.17M 0.35%
390,000
– –
BFRI icon
38
Biofrontera
BFRI
$16M
$766K 0.23%
+501,434
New +$695K
DFSC
39
DEFSEC Technologies
DFSC
$3.33M
$630K 0.19%
2,390
-258
-10% -$68.6K
EVOK
40
DELISTED
Evoke Pharma
EVOK
$516K 0.16%
+70,547
New +$599K
VCNX
41
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$432K 0.13%
58,365
+3
+0% +$26
DFSCW
42
DEFSEC Technologies Warrant
DFSCW
$77.8K 0.02%
598,500
– –
SVREW
43
SaverOne 2014 Ltd Warrant
SVREW
$42.6K 0.01%
568,194
– –
ABEO icon
44
Abeona Therapeutics
ABEO
$412M
– –
-787,769
Closed -$3.95M
APLT
45
DELISTED
Applied Therapeutics
APLT
– –
-1,659,039
Closed -$5.56M
APYX icon
46
Apyx Medical
APYX
$170M
– –
-2,040,540
Closed -$5.35M
ASPN icon
47
Aspen Aerogels
ASPN
$515M
– –
-1,804,484
Closed -$28.5M
GSIT icon
48
GSI Technology
GSIT
$259M
– –
-944,591
Closed -$2.49M
INDI icon
49
indie Semiconductor
INDI
$851M
– –
-2,255,000
Closed -$18.3M
LPSN icon
50
LivePerson
LPSN
$31.8M
– –
-107,327
Closed -$6.1M
1
2
3

Similar funds

VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

AIGH Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, AIGH Capital Management held 54 positions worth $333M, up 32% from $253M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

AIGH Capital Management deployed $69.2M of net new capital in Q1 2024, opening 15 new positions and adding to 11 existing holdings. Its largest new stake was Humacyte: 2,155,958 shares worth $6.71M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 56% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Brainsway, an estimated $4.96M trimmed.

  • AIGH Capital Management's largest Q1 2024 buy was Humacyte: 2,155,958 shares worth $6.71M.
  • AIGH Capital Management added most to Ideal Power in Q1 2024, an estimated $6.06M increase.
  • AIGH Capital Management's biggest Q1 2024 reduction was Brainsway, cutting an estimated $4.96M.
  • AIGH Capital Management fully exited Aspen Aerogels in Q1 2024, selling an estimated $28.5M.
  • AIGH Capital Management's ten largest holdings make up 65% of its $333M portfolio in Q1 2024.
  • AIGH Capital Management opened 15 new positions and closed 11 in Q1 2024.
  • AIGH Capital Management's portfolio value rose 32% quarter-over-quarter to $333M.

Based on AIGH Capital Management's 13F filing for Q1 2024, filed 14 May 2024.